Patricia S. Walker - Feb 23, 2022 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Director
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol
FBRX
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 04:06 PM
Previous filing
Feb 16, 2022
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Stock Option (right to buy) Award $0 +25K $0.00 25K Feb 23, 2022 Common Stock 25K $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant. "Date of Grant" shall mean February 23, 2022.